Activated prothrombin complex concentrate for reversal of oral factor Xa inhibitors at a level 1 trauma center

被引：1
|
作者：
Bobby, Lauren [1 ]
Westlake, Evan [1 ]
Esplin, Nathan [2 ]
Young, Sarah [1 ]
机构：
[1] Allegheny Gen Hosp, Dept Pharm, 320 North Ave, Pittsburgh, PA 15212 USA
[2] Allegheny Gen Hosp, Dept Neurosurg, 320 North Ave, Pittsburgh, PA 15212 USA
来源：
THROMBOSIS RESEARCH | 2021年 / 206卷
关键词：
Apixaban; Rivaroxaban; Reversal; Activated prothrombin complex concentrate (aPCC); Intracranial hemorrhage (ICH); Andexanet alfa; ANTICOAGULANTS; MANAGEMENT; OUTCOMES; FEIBA;
D O I：
10.1016/j.thromres.2021.08.005
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：33 / 35
页数：3
相关论文
共 50 条
  • [21] Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist Reversal
    Rowe, A. Shaun
    Dietrich, Scott K.
    Phillips, John W.
    Foster, Kaci E.
    Canter, Joshua R.
    CRITICAL CARE MEDICINE, 2018, 46 (06) : 943 - 948
  • [22] Hemostatic efficacy of four factor prothrombin complex concentrate in intracerebral hemorrhage patients receiving warfarin vs. factor Xa inhibitors
    Pon, Gregory
    Pelsue, Brittany
    Reddy, Sujan Teegala
    Parsha, Kaushik
    Zhang, Xu
    Gulbis, Brian
    Barreto, Andrew
    Savitz, Sean I.
    Escobar, Miguel
    Allison, Teresa A.
    THROMBOSIS RESEARCH, 2023, 229 : 46 - 52
  • [23] Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding: A Systematic Review and Meta-Analysis
    Nederpelt, Charlie J.
    Naar, Leon
    Krijnen, Pieta
    le Cessie, Saskia
    Kaafarani, Haytham M. A.
    Huisman, Menno V.
    Velmahos, George C.
    Schipper, Inger B.
    CRITICAL CARE MEDICINE, 2021, 49 (10) : E1025 - E1036
  • [24] Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
    Rech, Megan A.
    Masic, Dalila
    Hammond, Drayton A.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2021, 22 (02) : 163 - 169
  • [25] Reversal of rivaroxaban-induced anticoagulation with prothrombin complex concentrate, activated prothrombin complex concentrate and recombinant activated factor VII in vitro
    Perzborn, Elisabeth
    Heitmeier, Stefan
    Laux, Volker
    Buchmueller, Anja
    THROMBOSIS RESEARCH, 2014, 133 (04) : 671 - 681
  • [26] Andexanet versus prothrombin complex concentrates: Differences in reversal of factor Xa inhibitors in in vitro thrombin generation
    Lu, Genmin
    Lin, Joyce
    Bui, Khanh
    Curnutte, John T.
    Conley, Pamela B.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (08) : 1282 - 1294
  • [27] Safety of 4-factor prothrombin complex concentrate (4F-PCC) for emergent reversal of factor Xa inhibitors
    Tao, Jing
    Bukanova, Elena N.
    Akhtar, Shamsuddin
    JOURNAL OF INTENSIVE CARE, 2018, 6
  • [28] Prothrombin Complex Concentrates for Intracranial Hemorrhage on Factor Xa Inhibitors
    Benz, Alexander P.
    Eikelboom, John W.
    CIRCULATION, 2020, 141 (21) : 1690 - 1692
  • [29] Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study
    Siavash Piran
    Caroline Gabriel
    Sam Schulman
    Journal of Thrombosis and Thrombolysis, 2018, 45 : 486 - 495
  • [30] Efficacy and Safety of Andexanet Alfa Versus Four Factor Prothrombin Complex Concentrate for Emergent Reversal of Factor Xa Inhibitor Associated Intracranial Hemorrhage: A Systematic Review and Meta-Analysis
    Sarhan, Khalid
    Mohamed, Rashad G.
    Elmahdi, Reem Reda
    Mohsen, Youstina
    Elsayed, Asmaa
    Zayed, Dania Mosaad
    Elkholi, Menna A.
    Gabr, Nagat
    El-Bialy, Enjy M.
    Serag, Ibrahim
    NEUROCRITICAL CARE, 2025, 42 (02) : 701 - 714
12345